-
Alcon Research Ltd. v. Barr Laboratories Inc. DC CAFC
- 1:09-cv-00318
- D. Del.
- Judge: Richard G. Andrews
+1
- Filed: 04/30/2009
- Closed: 05/07/2014
- Latest Docket Entry: 07/08/2014
- PACER
- Docket updated daily
1
Plaintiff
4
Defendants
1
Accused
Product
5
Patents-in-Suit
1,834
Days in
Litigation
-
Alcon Research Ltd. v. Barr Laboratories Inc. DC CAFC
- 1:09-cv-00318
- D. Del.
- Judge: Richard G. Andrews
+1
- Filed: 04/30/2009
- Closed: 05/07/2014
- Latest Docket Entry: 07/08/2014
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Previously Presiding
Legrome D. Davis (until 10/09/2012)
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 9 |
The composition of claim 8 wherein the concentration of 1R-[1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-7-[3,5-dihydroxy-2-[3-h ydroxy-4-[3-(trifluoromethyl)-phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid, 1-methylethyl ester is selected from
view more
|
Valid
Entry 261 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 12 |
The method of claim 1 wherein the composition is a topically administrable ophthalmic composition.
|
Valid
Entry 261 |
-
Infringement
Barr Laboratories Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abbreviated New Drug Application No. 91- 411 | US 5,631,287 A |
12
|
No infringement
Entry 261
|
| Abbreviated New Drug Application No. 91- 411 | US 6,011,062 A |
9
|
No infringement
Entry 261
|
